NPRA Product Registration in Malaysia: Requirements and How to Apply

If you plan to manufacture, import, distribute, or sell pharmaceutical or medicinal products in Malaysia, NPRA approval is mandatory. This requirement applies to prescription medicines, over-the-counter drugs, health supplements, traditional remedies, and many wellness products that make therapeutic claims. 

Without this certification, you cannot legally clear customs, stock, or advertise your products in the Malaysian market. This guide provides a clear overview of the requirements and essential steps for foreign investors to secure NPRA approval.

How Malaysia Regulates Health and Pharmaceutical Products

Similar to FDA certification in other countries, the National Pharmaceutical Regulatory Agency (NPRA) is the primary regulator for Malaysia’s healthcare market. However, there is a key difference in how Malaysia organizes its oversight. 

While the US, for example, manages both food and drugs under one umbrella, Malaysia divides these responsibilities among specialized agencies within the Ministry of Health (MOH).

To ensure your product meets the correct standards, the MOH assigns a specific regulator based on your product’s form and intended use:

Product Type	Regulatory Authority	Product Type
Pharmaceuticals & Supplements	NPRA	Products in pharmaceutical dosage forms (capsules, tablets, soft gels) or those containing Scheduled Poisons.
Medical Devices	Medical Device Authority (MDA)	Instruments or apparatuses for diagnosis or treatment. (Drug-device combinations may involve both NPRA and MDA).
Food & Beverages	Food Safety & Quality Division (FSQD)	Conventional food forms with no medicinal or therapeutic claims.
Pet Food / Animal Products	Department of Veterinary Services (DVS)	Animal supplements and feed additives.

What Products Require NPRA Registration?

The NPRA specifically regulates product categories that fall under “medicinal” oversight in Malaysia. These categories include:

• Prescription medicines
• Over-the-counter (OTC) medicines
• Traditional and complementary medicines
• Health supplements and nutraceuticals
• Drug–medical device combination products, depending on their primary mode of action
• Cosmetics. While managed by the NPRA, these follow a simpler notification to the NPRA rather than full registration.

Essentially, your products fall under one of the categories above whenever their formulation, dose, or format moves them into “medicinal territory” under Malaysian law. Even if you market your product as a general wellness item elsewhere, Malaysia classifies it as medicinal if it meets any of the following criteria:

• Pharmaceutical Form: It is designed for specific dosing, such as capsules, tablets, soft gels, sublingual strips, or oral sprays.
• Potent Ingredients: It contains any “Scheduled Poison” listed under the Poisons Act 1952 (e.g., paracetamol, glucosamine, or tranexamic acid) or pharmacologically active substances like aspirin.
• High-Dose Actives: It exceeds medicinal dose thresholds. For example, plant sterols or stanols at 3.5 g per day, psyllium husk at 3.5 g per day, or senna at 0.5 g per dose.

What are Food-Drug Interphase (FDI) Products?

Many foreign brands face delays because their products fall within a “grey area” known as the Food–Drug Interphase (FDI). When a product doesn’t clearly fit as a food or a drug, a joint committee between the FSQD and NPRA conducts a formal review to decide which agency takes the lead for certification.

This classification is typically based on the presentation and claims of the product. For instance:

• Herbal drinks, protein shakes, or gummies can be regulated as food (FSQD) if marketed for general wellness or nutrition.
• The same products shift into medicinal (NPRA) jurisdiction the moment they claim to treat, prevent, or manage a specific condition (e.g., claiming to “lower cholesterol” or “control blood sugar”).

The same logic applies to devices. A patch, inhaler, or injector may seem like a medical device for the MDA to authorize. But if it delivers an active drug, the FDI regulates it based on its Primary Mode of Action (PMOA), which determines whether you require NPRA or MDA certification.

If you are not certain about your classification, Emerhub can initiate a Formal FDI Classification Assessment. This helps you avoid filing under the wrong category and losing months to reclassification.

Alternatively, you can also book a free consultation with our advisors if you need clarity on the process.

Who Needs to Obtain NPRA Approval in Malaysia?

NPRA regulates both products and the companies that place them on the market. Anyone involved in the supply chain must meet NPRA’s licensing and compliance requirements. This generally includes several key parties:

1. Manufacturers: Your manufacturing site, whether in Malaysia or overseas, must operate under Good Manufacturing Practice (GMP) standards recognised by NPRA.
2. Importers: The Malaysian entity bringing your product into the country is legally responsible for it. You must register your products before they can clear customs or enter distribution.
3. Distributors: Any company handling the sale, storage, and distribution of products must hold specific licenses (Import, Wholesale, or Retail).
4. Retailers: Pharmacies and clinics must ensure products are NPRA-registered and obtained through licensed distributors.

For foreign companies without a local entity, this usually means appointing a local Product Registration Holder and importer such as Emerhub, to act as your official representative with the NPRA and custom officials in Malaysia.

Key Requirements for NPRA Product Registration in Malaysia

The NPRA looks at whether your product can actually survive Malaysia’s climate and meet local regulatory standards. To secure NPRA registration, your products must meet the following requirements:

1. Local Representation: Under the Control of Drugs and Cosmetics Regulations 1984 local representation is mandatory for foreign companies to hold NPRA certification. You must either establish a local entity in Malaysia or appoint a Malaysian company to act as your Product Holder. 
2. Good Manufacturing Practice (GMP) Compliance: The NPRA must verify your manufacturing site’s GMP status. If your factory is in a PIC/S member country, the NPRA may accept your current certificate. Otherwise, auditors may require a physical site inspection.
3. Stability Data for Climatic Zone IVB: Malaysia is hot and humid (Climatic Zone IVB). You need to provide stability data conducted at 30°C and 75% relative humidity. Data from Europe, the US, or more temperate regions, is frequently rejected because it doesn’t reflect how the product behaves on Malaysian shelves.
4. Bioequivalence Studies: For generic pharmaceutical products, you must prove the product works the same as the original branded version. These must be performed at NPRA-accredited facilities.
5. Label and Packaging Mock-ups: NPRA reviews the actual packaging your product will carry on shelves. The artwork must show approved product names, strengths, directions for use, warnings, language format, and space for the NPRA registration number (MAL).
6. Complete Quality, Safety, and Efficacy Dossiers: You’ll need to provide full disclosure on what your product is, how it is made, and how it performs. This includes validated laboratory test results, manufacturing controls, and evidence that supports the product’s safety and intended use.

How to Secure NPRA Certification for Medicinal and Pharmaceutical Products

Before you begin the official product registration process, two critical starting points help you avoid delays and unnecessary costs. 

First, NPRA registration is product-specific and non-refundable, with fees typically ranging from RM 1,200 for traditional remedies to over RM 5,000 for new pharmaceutical products. Filing under the wrong agency can waste months of costly effort. Therefore, it’s crucial to confirm your exact registration route.

Secondly, only a locally incorporated company can hold a product registration. If you don’t have a local entity, you must appoint a licensed Malaysian representative, such as Emerhub, to serve as your Product Registration Holder (PRH). 

Once you meet these conditions, follow this step-by-step process to secure your certification:

Step 1: Product classification and QUEST 3+ setup

As your appointed Product Registration Holder (PRH), Emerhub experts will initiate the process, managing the official classification of your product and the technical setup required for submission.

• Before starting the digital application, we’ll verify your product’s category (e.g., medicine, OTC, or supplement) with the NPRA via a formal FDI Assessment. This validates your official registration route, subsequent fee structure and technical data you’ll need to disclose in the next steps.
• Then, we manage all digital transactions through the NPRA’s QUEST 3+ portal. This involves registering your membership and securing a mandatory physical USB Token (digital certificate), a process that typically takes 7 to 14 working days.

Step 2: Prepare the Technical Dossier in ACTD Format

This is the most time-consuming and substantive phase of the application. You must compile a comprehensive ASEAN Common Technical Dossier (ACTD), which includes:

• Quality Data: Manufacturing records, GMP certificates, and detailed formulation.
• Stability Data: Products must show stability under Malaysia’s specific climate conditions.
• Safety & Efficacy: Clinical or bioequivalence data may be required depending on the product type.
• Labelling: All packaging mock-ups must meet strict Malaysian labelling standards.

Step 3: NPRA Evaluation and Technical Queries

Once submitted, NPRA begins their scientific and regulatory assessment. During this phase, the agency will issue formal queries and requests for clarification on formulation, stability, labelling, or manufacturing controls. You’ll have to address these within NPRA’s timelines (generally within 21 days) to keep the application moving, or risk a re-application.

Step 4: Approval, MAL Number, and Licensing

With your dossier cleared, the Drug Control Authority (DCA) officially issues your approval and assigns a MAL registration number (for example, MAL2026XXXXN). This is the point where your product can officially enter the Malaysian market. 

Most applications take 116 to 245 working days to complete (between 5–12 months), depending on the product type and the scope of the technical review. Once approved, the registration is valid for five years.

From this point forward, Emerhub can manage the regulatory workload, including renewals, post-approval changes, and safety reporting. This keeps your product compliant in Malaysia without requiring you to set up or run a local company.

How to Import NPRA Regulated Products into Malaysia 

If you are planning to import NPRA-regulated products into Malaysia, it is essential to secure an Import License in addition to NPRA registration. To apply for this license, your company must be registered in Malaysia.

However, if you are looking to test the waters before committing to a local entity, Emerhub offers an Importer of Record (IOR) service. This allows you to move from NPRA registration to import and distribution seamlessly. With Emerhub as your partner, we’ll oversee the entire process, including:

• Acting as your PRH: To secure and maintain the MAL registration.
• Providing IOR Services: To handle customs clearance, import documentation, and tax management.
• Managing Compliance: Ensuring your products meet all packaging and storage requirements.

Planning to manufacture, import, or sell health products in Malaysia? Fill out the form below for a free consultation with our advisors!